Impact of COVID-19 Pandemic on Retinopathy of Prematurity Services in the Indian Public Healthcare System

Figures & data

Table 1 Comparative Analysis of the Volume of Retinopathy of Prematurity During the COVID-19 Pandemic Lockdown and During the Same Period in the Previous Year

	Pre-COVID	COVID-19 Lockdown	Odds Ratio
Newborns Screened	328	187
Incidence of ROP	10.37% (34/328 babies)	18.72% (35/187 babies)	2.08 [1.7–3.8]
Incidence of ST-ROP	11.76% (4/34 babies)	34.29% (12/35 babies)	3.9 [1.1–13.7]
Newborns with ROP requiring Laser Therapy	11.76% (4/34 babies)	34.29% (12/35 babies)	3.9 [1.1–13.7]

Abbreviations: ROP, Retinopathy of prematurity; ST-ROP, Sight-threatening retinopathy of prematurity.

Table 2 Staging of Retinopathy of Prematurity During the COVID-19 Pandemic Lockdown and During the Same Period in the Previous Year

	ROP Staging	Pre-COVID (Number of Eyes)	COVID-19 Lockdown (Number of Eyes)
Treated Eyes	Zone 1 Stage 2+	0	2
	Zone 1 Stage 3+	0	5
	Zone 2 Stage 2+	3	3
	Zone 2 Stage 3+	1	2
	APROP	0	0
Untreated Eyes	Zone 1 Stage 2 (No Plus)	4	7
	Zone 2 Stage 3 (No Plus)	0	0
	Zone 1 Stage 2 (No Plus)	26	16
	Zone 2 Stage 3 (No Plus)	0	0

Abbreviations: ROP, Retinopathy of prematurity; AP-ROP, Aggressive posterior retinopathy of prematurity.